61/100B51.365
USD
-0.33
(-0.64%)
Market Closed
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Genmab A total debt 2002–2026What is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
Genmab A/S ADS's total debt was 5.20B USD on 30 September 2026, up 3,560.6% on a year before. At the end of fiscal year 2025 it was 5.43B USD.
Last updated 8 Nov 2026 · Next report 16 Feb 2027
Total debt
Growth
| Fiscal year | Period ending | Total debt | Growth | Cash and short-term investments | Net cash | Debt to equity |
|---|---|---|---|---|---|---|
| Latest quarter | 30 Sept 2026 | 5.20B | +3,560.56% | 1.86B | -3.34B | 0.82 |
| FY2025 | 31 Dec 2025 | 5.43B | +427.31% | 1.71B | -3.71B | 0.93 |
| FY2024 | 31 Dec 2024 | 1.03B | +33.64% | 21.10B | 20.07B | 0.03 |
| FY2023 | 31 Dec 2023 | 770.00M | +28.98% | 28.14B | 27.37B | 0.02 |
| FY2022 | 31 Dec 2022 | 597.00M | +40.47% | 22.32B | 21.73B | 0.02 |
| FY2021 | 31 Dec 2021 | 425.00M | +33.23% | 19.34B | 18.91B | 0.02 |
| FY2020 | 31 Dec 2020 | 319.00M | +76.24% | 16.08B | 15.76B | 0.02 |
| FY2019 | 31 Dec 2019 | 181.00M | — | 10.97B | 10.79B | 0.01 |
| FY2018 | 31 Dec 2018 | 0.00 | — | 6.11B | 6.11B | 0.00 |
| FY2017 | 31 Dec 2017 | 0.00 | — | 5.42B | 5.42B | 0.00 |
| FY2016 | 31 Dec 2016 | 0.00 | -100.00% | 3.92B | 3.92B | 0.00 |
| FY2015 | 31 Dec 2015 | 118.00K | -66.76% | 3.49B | 3.49B | 0.00 |
| FY2014 | 31 Dec 2014 | 355.00K | -85.71% | 2.66B | 2.66B | 0.00 |
| FY2013 | 31 Dec 2013 | 2.49M | -56.10% | 1.56B | 1.55B | 0.00 |
| FY2012 | 31 Dec 2012 | 5.66M | -52.22% | 1.50B | 1.50B | 0.01 |
| FY2011 | 31 Dec 2011 | 11.85M | -91.14% | 1.10B | 1.09B | 0.02 |
| FY2010 | 31 Dec 2010 | 133.72M | +436.11% | 1.65B | 1.52B | 0.12 |
| FY2009 | 31 Dec 2009 | 24.94M | +69.69% | 1.28B | 1.25B | 0.02 |
| FY2008 | 31 Dec 2008 | 14.70M | -6.18% | 70.01M | 55.31M | 0.01 |
| FY2007 | 31 Dec 2007 | 15.67M | -13.95% | 3.69B | 3.68B | 0.01 |
| FY2006 | 31 Dec 2006 | 18.21M | -20.97% | 1.72B | 1.71B | 0.01 |
| FY2005 | 31 Dec 2005 | 23.04M | -20.58% | 1.25B | 1.23B | 0.02 |
| FY2004 | 31 Dec 2004 | 29.00M | +20.16% | 419.57M | 390.56M | 0.02 |
| FY2003 | 31 Dec 2003 | 24.14M | +75.22% | 308.92M | 284.78M | 0.02 |
| FY2002 | 31 Dec 2002 | 13.78M | — | 252.95M | 239.17M | 0.01 |
| Quarter | Period ending | Total debt | Growth on a year before | Cash and short-term investments | Net cash | Debt to equity |
|---|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 5.20B | +3,560.56% | 1.86B | -3.34B | 0.82 |
| Q2 FY2026 | 30 Jun 2026 | 5.27B | +3,463.58% | 1.50B | -3.77B | 0.89 |
| Q1 FY2026 | 31 Mar 2026 | 5.35B | +3,776.43% | 1.52B | -3.83B | 0.94 |
| Q4 FY2025 | 31 Dec 2025 | 5.43B | +427.31% | 1.71B | -3.71B | 0.93 |
| Q3 FY2025 | 30 Sept 2025 | 142.00M | -85.61% | 3.41B | 3.27B | 0.02 |
| Q2 FY2025 | 30 Jun 2025 | 147.97M | -85.48% | 2.90B | 2.75B | 0.03 |
| Q1 FY2025 | 31 Mar 2025 | 138.04M | -86.33% | 2.70B | 2.57B | 0.03 |
| Q4 FY2024 | 31 Dec 2024 | 1.03B | +33.64% | 21.10B | 20.07B | 0.03 |
| Q3 FY2024 | 30 Sept 2024 | 987.00M | +24.46% | 17.32B | 16.33B | 0.03 |
| Q2 FY2024 | 30 Jun 2024 | 1.02B | +26.90% | 15.73B | 14.71B | 0.03 |
| Q1 FY2024 | 31 Mar 2024 | 1.01B | +21.83% | 29.58B | 28.57B | 0.03 |
| Q4 FY2023 | 31 Dec 2023 | 770.00M | +28.98% | 28.14B | 27.37B | 0.02 |
| Q3 FY2023 | 30 Sept 2023 | 793.00M | +26.07% | 27.53B | 26.73B | 0.03 |
| Q2 FY2023 | 30 Jun 2023 | 803.00M | +26.66% | 24.88B | 24.08B | 0.03 |
| Q1 FY2023 | 31 Mar 2023 | 829.00M | +99.28% | 24.54B | 23.72B | 0.03 |
| Q4 FY2022 | 31 Dec 2022 | 597.00M | +40.47% | 22.32B | 21.73B | 0.02 |
| Q3 FY2022 | 30 Sept 2022 | 629.00M | +43.94% | 23.79B | 23.16B | 0.02 |
| Q2 FY2022 | 30 Jun 2022 | 634.00M | +43.12% | 21.62B | 20.98B | 0.03 |
| Q1 FY2022 | 31 Mar 2022 | 416.00M | +10.05% | 19.99B | 19.57B | 0.02 |
| Q4 FY2021 | 31 Dec 2021 | 425.00M | +33.23% | 19.34B | 18.91B | 0.02 |
| Q3 FY2021 | 30 Sept 2021 | 437.00M | +29.67% | 18.74B | 18.31B | 0.02 |
| Q2 FY2021 | 30 Jun 2021 | 443.00M | +24.44% | 17.88B | 17.43B | 0.02 |
| Q1 FY2021 | 31 Mar 2021 | 378.00M | +1,377.42% | 18.08B | 17.71B | 0.02 |
| Q4 FY2020 | 31 Dec 2020 | 319.00M | +76.24% | 16.08B | 15.76B | 0.02 |
| Q3 FY2020 | 30 Sept 2020 | 337.00M | +78.67% | 17.47B | 17.13B | 0.02 |
| Q2 FY2020 | 30 Jun 2020 | 356.00M | +83.46% | 12.78B | 12.43B | 0.02 |
| Q1 FY2020 | 31 Mar 2020 | 25.59M | -87.17% | 1.91B | 1.88B | 0.01 |
| Q4 FY2019 | 31 Dec 2019 | 181.00M | — | 10.97B | 10.79B | 0.01 |
| Q3 FY2019 | 30 Sept 2019 | 188.61M | — | 11.12B | 10.93B | 0.02 |
| Q2 FY2019 | 30 Jun 2019 | 194.05M | — | 6.95B | 6.76B | 0.02 |
| Q1 FY2019 | 31 Mar 2019 | 199.43M | — | 6.83B | 6.63B | 0.02 |
| Q4 FY2018 | 31 Dec 2018 | 0.00 | — | 6.11B | 6.11B | 0.00 |
| Q3 FY2018 | 30 Sept 2018 | 0.00 | — | 5.90B | 5.90B | 0.00 |
| Q2 FY2018 | 30 Jun 2018 | 0.00 | — | 6.07B | 6.07B | 0.00 |
| Q1 FY2018 | 31 Mar 2018 | 0.00 | — | 5.70B | 5.70B | 0.00 |
| Q4 FY2017 | 31 Dec 2017 | 0.00 | — | 5.42B | 5.42B | 0.00 |
| Q3 FY2017 | 30 Sept 2017 | 0.00 | — | 5.18B | 5.18B | 0.00 |
| Q2 FY2017 | 30 Jun 2017 | 0.00 | — | 5.21B | 5.21B | 0.00 |
| Q1 FY2017 | 31 Mar 2017 | 0.00 | -100.00% | 4.75B | 4.75B | 0.00 |
| Q4 FY2016 | 31 Dec 2016 | 0.00 | -100.00% | 3.92B | 3.92B | 0.00 |
| Q3 FY2016 | 30 Sept 2016 | 0.00 | -100.00% | 3.94B | 3.94B | 0.00 |
| Q2 FY2016 | 30 Jun 2016 | 0.00 | -100.00% | 3.76B | 3.76B | 0.00 |
| Q1 FY2016 | 31 Mar 2016 | 59.00K | -80.07% | 3.49B | 3.49B | 0.00 |
| Q4 FY2015 | 31 Dec 2015 | 118.00K | -66.76% | 3.49B | 3.49B | 0.00 |
| Q3 FY2015 | 30 Sept 2015 | 178.00K | -57.11% | 3.21B | 3.21B | 0.00 |
| Q2 FY2015 | 30 Jun 2015 | 237.00K | -50.00% | 2.96B | 2.96B | 0.00 |
| Q1 FY2015 | 31 Mar 2015 | 296.00K | -44.67% | 2.95B | 2.94B | 0.00 |
| Q4 FY2014 | 31 Dec 2014 | 355.00K | -85.71% | 2.66B | 2.66B | 0.00 |
| Q3 FY2014 | 30 Sept 2014 | 415.00K | -99.74% | 2.64B | 2.64B | 0.00 |
| Q2 FY2014 | 30 Jun 2014 | 474.00K | -89.48% | 2.58B | 2.58B | 0.00 |
| Q1 FY2014 | 31 Mar 2014 | 535.00K | -88.69% | 2.53B | 2.53B | 0.00 |
| Q4 FY2013 | 31 Dec 2013 | 2.49M | -56.10% | 1.56B | 1.55B | 0.00 |
| Q3 FY2013 | 30 Sept 2013 | 156.71M | +2,021.09% | 1.65B | 1.49B | 0.31 |
| Q2 FY2013 | 30 Jun 2013 | 4.51M | -48.23% | 1.55B | 1.54B | 0.01 |
| Q1 FY2013 | 31 Mar 2013 | 4.73M | -54.09% | 1.49B | 1.48B | 0.01 |
| Q4 FY2012 | 31 Dec 2012 | 5.66M | -52.22% | 1.50B | 1.50B | 0.01 |
| Q3 FY2012 | 30 Sept 2012 | 7.39M | -44.80% | 1.18B | 1.17B | 0.02 |
| Q2 FY2012 | 30 Jun 2012 | 8.71M | -41.59% | 944.17M | 935.47M | 0.02 |
| Q1 FY2012 | 31 Mar 2012 | 10.31M | -37.18% | 1.02B | 1.01B | 0.02 |
| Q4 FY2011 | 31 Dec 2011 | 11.85M | -91.14% | 1.10B | 1.09B | 0.02 |
| Q3 FY2011 | 30 Sept 2011 | 13.38M | -31.90% | 1.21B | 1.20B | 0.03 |
| Q2 FY2011 | 30 Jun 2011 | 14.90M | -30.18% | 1.30B | 1.29B | 0.02 |
| Q1 FY2011 | 31 Mar 2011 | 16.41M | -28.85% | 1.44B | 1.43B | 0.02 |
| Q4 FY2010 | 31 Dec 2010 | 133.72M | +436.11% | 1.65B | 1.52B | 0.12 |
| Q3 FY2010 | 30 Sept 2010 | 19.65M | — | 1.69B | 1.67B | 0.02 |
| Q2 FY2010 | 30 Jun 2010 | 21.35M | — | 920.25M | 898.90M | 0.02 |
| Q1 FY2010 | 31 Mar 2010 | 23.06M | — | 1.07B | 1.05B | 0.02 |
| Q4 FY2009 | 31 Dec 2009 | 24.94M | — | 1.28B | 1.25B | 0.02 |
Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.
Total debt counts commercial paper, term debt and lease liabilities.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Stock buybacks,Balance sheet
Common questions about Genmab A's debt
Source: Financial Modeling Prep